CCL27 and inflammatory bowel disease: To further validate the specific impact of an altered intestinal glycome in the regulation of ILC-mediated gut immunity in IBD immunopathogenesis, we investigated whether changes in gut mucosa glycosylation may be linked to alterations in ILC3 module in human IBD.